Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Long-term benefit with photodynamic therapy for Barrett's cancer

This month's Gastrointestinal Endoscopy reports excellent long-term results of photodynamic therapy with 5-aminolevulinic acid for high-grade intraepithelial neoplasia or mucosal cancer, offering it as an alternative to surgical esophagectomy and endoscopic resection.

News image

fiogf49gjkf04

Photodynamic therapy with 5-aminolevulinic acid has proven to be safe and effective in patients with early neoplasia in Barrett's esophagus.

However, long-term results in patients with high-grade intraepithelial neoplasia or with early cancer are still lacking.

Dr Oliver Pech and colleagues from Germany evaluated the efficacy of photodynamic therapy with 5-aminolevulinic acid.

The researchers analyzed the effect of this treatment on the survival of 66 patients with early Barrett's neoplasia.

The team applied 5-aminolevulinic acid orally calculated at 60 mg per kg body weight 4 to 6 hours before photodynamic therapy.

Protoporphyrin IX induced by oral administration of 5-aminolevulinic acid was used as the photosensitizer.

Disease-free survival in patients with high-grade intraepithelial neoplasia was 89%
Gastrointestinal Endoscopy

The research team maintained acid suppression in all patients.

The researchers reported that between 1996 and 2002, 667 patients with early neoplasia in Barrett's esophagus were referred for local endoscopic therapy.

The team noted that a total of 558 patients fulfilled the criteria for local endoscopic therapy.

However, only 66 patients with a mean age of 61 years were treated by photodynamic therapy.

The patients were separated into 2 groups, with 35 with high-grade intraepithelial neoplasia in Group 1 and 31 patients with early adenocarcinoma in Group 2.

The researchers reported that a total of 82 photodynamic therapies with 5-aminolevulinic acid were performed.

The team found that 34 of the 35 patients in Group 1 and all patients in group 2 achieved a complete response during a median follow-up period of 37 months.

The researchers observed 1 local recurrence in Group 1 and 10 in group 2.

The team noted that 7 patients died during follow-up, but that all deaths were not tumor related.

No major complications were observed.

The team noted that disease-free survival in patients with high-grade intraepithelial neoplasia was 89%, and, in for mucosal cancer, it was 68%.

The calculated 5-year survival was 97% in Group 1 and 80% in Group 2, but there occurred no death related to Barrett's neoplasia.

Dr Pech's team concluded, “This study shows excellent long-term results of photodynamic therapy with 5-aminolevulinic acid in patients with high-grade intraepithelial neoplasia or mucosal cancer.”

Photodynamic therapy with 5-aminolevulinic acid might be offered as an alternative to surgical esophagectomy and endoscopic resection, especially in cases with multifocal Barrett's neoplasia.”

Gastrointest Endosc 2005: 62(1): 24
18 July 2005

Go to top of page Email this page Email this page to a colleague

 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Post‐operative complications in elderly IBD
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Esophageal dilatation in clinical practice 
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 30 April 2018 
Patient-reported outcome measures in IBD trials
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's
 24 April 2018 
Microbiome in athletes vs sedentary subjects
 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure
 23 April 2018 
Antibody suitable for further clinical development to complement existing therapeutic strategies for HCV
 23 April 2018 
Sleep deprivation and NAFLD in the USA

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us